[
  {
    "ts": "2025-09-21T13:16:15+00:00",
    "headline": "MDxHealth Completes Bio Techne ExoDx Acquisition to Bolster Precision Diagnostics",
    "summary": "MDxHealth SA (NASDAQ:MDXH) is among the best fundamentally strong penny stocks to buy right now. On September 15, 2025, MDxHealth SA (NASDAQ:MDXH) announced the completion of its acquisition of Bio-Techne Corporation’s ExoDx business, including the ExoDx Prostate test. This $15 million transaction is part of the company’s plan to strengthen its precision diagnostics portfolio. Earlier […]",
    "url": "https://finance.yahoo.com/news/mdxhealth-completes-bio-techne-exodx-131615374.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ed514452-5f08-348b-a7ce-0e83122f6ffe",
      "content": {
        "id": "ed514452-5f08-348b-a7ce-0e83122f6ffe",
        "contentType": "STORY",
        "title": "MDxHealth Completes Bio Techne ExoDx Acquisition to Bolster Precision Diagnostics",
        "description": "",
        "summary": "MDxHealth SA (NASDAQ:MDXH) is among the best fundamentally strong penny stocks to buy right now. On September 15, 2025, MDxHealth SA (NASDAQ:MDXH) announced the completion of its acquisition of Bio-Techne Corporation’s ExoDx business, including the ExoDx Prostate test. This $15 million transaction is part of the company’s plan to strengthen its precision diagnostics portfolio. Earlier […]",
        "pubDate": "2025-09-21T13:16:15Z",
        "displayTime": "2025-09-21T13:16:15Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/9ffd859b1c212697c3b1eef329f9471a",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UczN49bs6CU5IYPu3h5TLg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/9ffd859b1c212697c3b1eef329f9471a.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mnvOYdVCTF0GlybCLhtHLg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/9ffd859b1c212697c3b1eef329f9471a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mdxhealth-completes-bio-techne-exodx-131615374.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mdxhealth-completes-bio-techne-exodx-131615374.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDXH"
            },
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]